Cargando…
Metformin activates Wnt/β-catenin for the treatment of diabetic osteoporosis
BACKGROUND: With the deepening of social aging, the incidence rate of osteoporosis and diabetes continues to rise. More and more clinical studies show that diabetes is highly correlated with osteoporosis. Diabetes osteoporosis is considered as a metabolic bone disease of diabetes patients. This stud...
Autores principales: | Huang, Xiaopeng, Li, Siyun, Lu, Wenjie, Xiong, Longjiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306077/ https://www.ncbi.nlm.nih.gov/pubmed/35869471 http://dx.doi.org/10.1186/s12902-022-01103-6 |
Ejemplares similares
-
Network pharmacology identifies fisetin as a treatment for osteoporosis that activates the Wnt/β-catenin signaling pathway in BMSCs
por: Liang, Guihong, et al.
Publicado: (2023) -
Gossypol Promotes Wnt/β-Catenin Signaling through WIF1 in Ovariectomy-Induced Osteoporosis
por: Liang, Jinqian, et al.
Publicado: (2019) -
PHF8 promotes osteogenic differentiation of BMSCs in old rat with osteoporosis by regulating Wnt/β-catenin pathway
por: Pan, Feng, et al.
Publicado: (2022) -
SAMMSON drives the self-renewal of liver tumor initiating cells through EZH2-dependent Wnt/β-catenin activation
por: Li, Xiaopeng, et al.
Publicado: (2017) -
The Wnt/β-catenin signaling pathway inhibits osteoporosis by regulating the expression of TERT: an in vivo and in vitro study
por: Cai, Yuanqing, et al.
Publicado: (2023)